Susan Young Rojahn

A View from Susan Young Rojahn

Stem Cells Help Night-Blind, Bald, Heartbroken Mice

Three dramatic results from tests of stem cell therapies could one day be repeated in humans.

  • April 18, 2012

Nature News reports today on three different studies that successfully used stem cell therapies to sprout new hair on bald mice, restore some vision to night-blind mice, and improve the heart function of mice with a cardiac injury. All three methods could eventually be adapted for use in humans.

Robert Lanza, Chief Scientific Officer at Advanced Cell Technologies, a regenerative medicine biotechnology company, told Nature:

“By the time we grow old, doctors are going to look back and say, ‘Can you believe people used to go bald, go blind or even have their leg cut off from vascular disease?’ —then [they] will treat the problem with an injection of [stem] cells.”

In January Lanza’s company reported that embryonic stem cells could be safely injected into the eyes of human patients suffering deteriorating vision, although the efficacy of the treatment is unknown.

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus ad-free web experience, select discounts to partner offerings and MIT Technology Review events

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.